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Evaluation of the Endurant stent graft under
instructions for use vs off-label conditions for
endovascular aortic aneurysm repair
Giovanni Torsello, MD,a,b Nicola Troisi, MD,a,b Konstantinos P. Donas, MD,b and
Martin Austermann, MD,a Münster, Germany
Background:This study evaluated the early and intermediate results of endovascular aortic aneurysm repair (EVAR) using
the Endurant stent graft (Medtronic Cardiovascular, Santa Rosa, Calif) in patients treated according to device-specific
instructions for use (IFU) for the proximal aortic neck compared with those obtained in patients treated in an off-label
(OL) situation.
Methods: Between November 2007 and March 2010, 177 consecutive patients with abdominal aortic aneurysms (AAAs)
were treated with the Endurant stent graft at our centers. The IFU for the Endurant stent graft included a proximal neck
of 15 mm in length and <75° of angulation or 10 mm of neck length and <60° of angulation. The 121 patients (68.4%)
operated on according to IFU were compared with 56 (31.6%) who underwent EVAR in OL circumstances to evaluate
significant differences in demographics, intraoperative technical factors, and early (30 days) and intermediate outcomes
(1 year).
Results: Significantly more patients were aged >80 years in the OL group (37.5% vs 19%, P  .008), and they also had
larger aneurysms (59 10.6 vs 55.9 10.8mm,P .05) and required a longer procedure time (69.3 27.2 vs 60.8 20.4
minutes, P .02). At 30 days, the risk of type I endoleak was higher in the OL group (2 patients, 3.6% vs 0 in IFU), but this
did not reach statistical significance (P  .09). The two groups were similar in rates of perioperative mortality, major
morbidity, technical success, clinical success, complications, and reinterventions. At 1 year, there were no differences
between the two groups in survival, freedom from any device-related reinterventions, and freedom from graft thrombo-
sis. Estimated 1-year freedom from type I endoleak was 100% in the IFU group vs 93.3% in the OL group (P  .01).
Conclusions: In patients with both normal and complex anatomy of the proximal aortic neck, the Endurant stent graft
obtained acceptable results, with no difference in survival, morbidity, or reinterventions. However, there was a greater
risk of type I endoleak when OL indications were applied. Longer term follow-up is required to evaluate the effectiveness
of this endograft in preventing late aneurysm-related complications. ( J Vasc Surg 2011;54:300-6.)
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gSince its introduction in 1991,1 endovascular repair
(EVAR) of abdominal aortic aneurysms (AAAs) has been
rapidly accepted by physicians and patients; this less invasive
treatment method offers lower perioperative risks, even if
the long-term results remain still controversial.2-4 Because
of its low risk of major adverse events in the perioperative
period, proponents of EVAR advocate its use in all patients
with suitable anatomy, above all in those considered at high
surgical risk.5 However, EVAR must satisfy several ana-
tomic criteria of feasibility, and unfortunately, adverse anat-
omy, particularly of the proximal neck, has often found in
patients at high surgical risk.6
The presence of a proximal neck 10 mm or an angu-
lation of the infrarenal neck 60°, or both, represents an
independent risk factor for periprocedural and late compli-
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300ations after EVAR7-10; for this reason, several strategies
ave been investigated to overcome the limitations related
o a very short proximal aortic neck, even if the reported
eries are very limited and the long-term results must be
etter established.11,12
During the last years, new grafts have been proposed to
xpand the indications for EVAR to patients with a hostile
natomy of the proximal aortic neck.13-15 First-generation
tent grafts relied on a variety of proximal attachments,
ncluding radial force, suprarenal stents, barbs, and colum-
ar strength. The need to treat high-risk patients with a
ostile aortic neck anatomy extended the use of the stent
rafts even in off-label (OL) situations, but the applications
utside of anatomically specific instructions for use (IFU)
eem to affect the long-term results of these first-generation
evices.16
The Endurant stent graft (Medtronic Cardiovascular,
anta Rosa, Calif) seems to be effective and safe even in
atients with complex anatomy, allowing a broader group
f patients to be treated with EVAR.17-19 The Endurant
tent graft relies on suprarenal fixation with a five-peak
lectropolished stent with anchoring pins with a high de-
ree of flexibility using an M-shaped stent to overcome the
imitations of earlier stent graft designs. The Endurant stent
raft also has anatomic constraints, but these are less strict
han those required by first-generation stent grafts.
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Volume 54, Number 2 Torsello et al 301The aim of this study was to document the intraopera-
tive, early (30 days), and intermediate results of the Endu-
rant stent graft in patients treated according to device-
specific IFU and compare them with results obtained in
patients treated in OL situations.
METHODS
Patient population. Between November 2007 and
March 2010, 558 patients with AAA were treated at our
centers: 264 with open repair, 177 with the Endurant stent
graft, 51 with other standard devices, 18 with standard
devices associated with the “chimney” technique, and 48
with fenestrated/branched custom-made devices. We
adopted some criteria of selection for EVAR: we preferred
to use a fenestrated/branched graft when the aneurysmal
sac involved the renal arteries or when the neck was 2
mm; in case of a neck ranging between 3 and 5 mm, we
used standard devices associated with the “chimney” tech-
nique; if the neck was 5 mm, we used standard devices
associated with the “chimney” technique or in an OL
situation.
The 177 patients treated with the Endurant stent graft
at our centers were included in this study. All data concern-
ing these interventions were prospectively collected in a
dedicated database with 130 fields, including demographic
data, preoperative risk factors, clinical and diagnostic pre-
operative assessments, intraoperative features, and early
(30-day) and (1-year) intermediate results.
The manufacturer’s IFU recommended a proximal aor-
tic neck15 mm in length with75° infrarenal angulation
or a proximal aortic neck 10 mm with 60° infrarenal
angulation. The 121 patients (68.4%) operated on accord-
ing to IFU were compared with 56 (31.6%) who under-
went EVAR in an OL situation to evaluate significant
differences in demographics, intraoperative technical fac-
tors, and early (30-day) and intermediate (1-year) out-
comes. Patients treated in an OL situation were required to
be nonoperative candidates or at high risk for surgical
repair.20 Patients were given the options of open surgical
repair or EVAR with the device on an OL use. Risks and
benefits of each option were carefully chosen by the pa-
tients and physicians. All patients gave their written con-
sent, approved by the Ethics Committee, to the procedure.
Preoperatively, all patients underwent an assessment of
clinical history, physical examination, chest radiograph, and
electrocardiogram. Laboratory tests included complete
blood count, coagulative parameters, and blood chemis-
tries. Duplex ultrasound (DUS) imaging was performed of
the aortoiliac and supra-aortic vessels. Within 3 months
before the procedure, all patients underwent a computed
tomography angiography (CTA) with at least 1.5-mm re-
construction of the entire aorta. All preoperative diagnostic
measurements were performed with Osirix 3.2 software
(Pixmeo, Geneva, Switzerland).
Operative technique. Endovascular procedures were
performed in a hybrid operating room under fluoroscopic
control (Axiom Artus FA, Siemens Medical Solutions,
Forchheim, Germany). Initially, an intraoperative angiog- eaphy with nonionic contrast medium was performed.
hrough the contralateral access, the stent graft with its
elivery system was advanced using a 260-cm Lunderquist
tiff wire (Cook Inc, Bloomington, Ind). When the proxi-
al radiopaque markers were aligned with the origin of the
ower renal artery, the delivery was performed without
eployment of the suprarenal stent. The position of the
tent graft was optimized before the suprarenal stent was
eployed.
After cannulation of the contralateral gate and retro-
rade angiographic identification of the iliac bifurcation,
he contralateral limb was inserted through the opposite
ite onto a 260-cm Lunderquist wire and was deployed. A
ompletion angiography was always performed to verify
echnical success. For adequate sealing of the stent graft,
allooning of the proximal neck, the docking zone, and the
liac legs were performed in all cases.17
Definitions, follow-up, and statistical analysis. Tech-
ical success was defined as the successful passage of the
elivery system through the iliac vessels, the correct deploy-
ent of the device, the appropriate positioning of the
ontralateral limb, and the complete withdrawal of the
elivery system, freedom from conversion, and absence of
ype I/III endoleak. Clinical success was defined as free-
om from aneurysm rupture, expansion (5 mm), conver-
ion to open repair, type I/III endoleak, graft infection or
hrombosis, and aneurysm-related death.
The follow-up protocol included physical examination
nd DUS and CTA at discharge. CTA was then performed
t 6 months, at 1 year, and yearly thereafter, and DUS was
one between 3 and 6 months after the procedure, and
hen yearly thereafter.
Statistical analysis was performed by using SPSS 15.0
oftware (SPSS Inc, Chicago, Ill). General characteristics,
reoperative risk factors, clinical and preoperative diagnos-
ic assessments, intraoperative features, and early (30-day)
nd intermediate (1-year) results were analyzed and com-
ared by means of 2 test or Fisher test when necessary. In
ase of mean comparison, t test for coupled values with 95%
onfidence intervals (CI) was adopted. Univariate and mul-
ivariate (stepwise logistic regression analysis) analysis of
actors affecting the 30-day results in mortality, major
orbidity, technical, and clinical success was performed in
he OL group. Statistical significance was defined at values
f P  .05.
Follow-up data were analyzed by Kaplan-Meier life-
able analysis, and results in subgroups were compared by
he log-rank test. A multivariate analysis with Cox regres-
ion test was performed in the OL group to identify inde-
endent preoperative and intraoperative predictors of poor
ntermediate outcomes.
ESULTS
Preoperative clinical and anatomic features. Patient
emographic data and preoperative risk factors are summa-
ized in Table I. The two groups were homogeneous,
xcept for a higher percentage of patients aged80 years in
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August 2011302 Torsello et althe OL group (37.5% vs 19%, P  .008). Mean preopera-
tive diagnostic assessments are listed in Table II. Mean
comparison showed that patients in the OL group had a
larger aneurysm size (59  10.6 vs 55.9  10.8 mm, P 
.05) and had more complex aortoiliac anatomy in length/
angulation of the proximal aortic neck and angulation of
the iliac axis. In the OL group, 27 patients (48.2%) had a
proximal aortic neck 10 mm, 22 (39.3%) had an infrare-
nal angulation of the proximal aortic neck 75°, and the
remaining 7 (12.5%) showed both features.
Intraoperative results. Local or regional anesthesia
Table I. Demographic data and preoperative risk factors
Variablea
IFU OL
P(n  121) (n  56)
Age, years 73 75.3 .08
Male sex 113 (93.4) 48 (85.7) .09
Age 80 years 23 (19) 21 (37.5) .008b
Smoking 103 (85.1) 47 (83.9) .5
Hypertension 106 (87.6) 49 (87.5) .58
Hypercholesterolemia 56 (46.3) 28 (50) .38
Diabetes mellitus 17 (14) 8 (14.3) .56
Coronary artery disease 69 (57) 29 (51.8) .31
History of MI 48 (39.7) 19 (33.9) .29
COPD 57 (47.1) 26 (46.4) .53
Cerebrovascular disease 25 (20.7) 10 (17.9) .41
Peripheral artery disease 43 (35.5) 19 (33.9) .49
Chronic renal failurec 15 (12.4) 10 (17.9) .23
Dialysis 1 (0.8) 1 (1.8) .53
Previous laparotomy 26 (21.5) 17 (30.3) .14
ASA classification III-IV 100 (82.6) 50 (89.3) .18
ASA, American Society of Anesthesiologists; COPD, chronic obstructive
pulmonary disease; IFU, instructions for use; MI, myocardial infarction; OL,
off label.
aContinuous data are presented as the mean, and categoric data are pre-
sented as number (%).
bStatistically significant.
cDefined as a serum creatinine value 1.5 mg/dL.
Table II. Preoperative diagnostic assessment
Variable
IFU
(n  121)
OL
(n  56)
PMean  SD Mean  SD
Neck diameter, mm
At renal level 24.8  3.3 25  3.5 .68
At beginning of
aneurysmal sac 25.8  3.3 26.2  3.9 .49
Aneurysm diameter,
mm 55.9  9.8 59  10.6 .05a
Aortic bifurcation
diameter, mm 30.5  9.2 32.9  10 .12
Neck length, mm 23.6  10.2 13.1  8.1 .001a
Proximal neck
angle, degrees 34.6  16.5 60.3  22.6 .001a
Right iliac angle,
degrees 39.1  16.3 43.9  20.9 .1
Left iliac angle,
degrees 40.6  19.5 49  23.5 .01a
IFU, Instructions for use; OL, off label; SD, standard deviation.
aStatistically significant.was used in 116 IFU patients (95.9%) and in 52 OL tatients (92.3%; P  .3). Intravenous heparin (5000 IU)
nd antibiotic prophylaxis were routinely administered. A
ilateral percutaneous femoral access approach was used in
17 IFU patients (96.7%) and in 55 OL patients (98.2%;
 .76). An aortouniiliac graft was deployed in only four
ases, comprising three IFU (2.5%) and one (1.8%) OL
atient (P  .62). The deployment of at least one iliac
xtension was necessary in 37 (66.1%) in the OL group vs
8 (39.7%) in the IFU group (P .001). Furthermore, 43
ntraoperative adjunctive procedures were performed,
omprising 30 in the IFU group (24.8%) vs 13 in the OL
roup (23.2%; P  .49; Table III).
Intraoperative technical success was achieved in all
ases. No intraoperative conversion, migration, type I/III
ndoleak, major complication, or death was recorded. At
ompletion angiography, a type II endoleak was recorded
n 15 patients (12.4%) in the IFU group and in 8 patients
14.3%) in the OL group (P  .44).
Early results (30 days). After the procedure, 84 pa-
ients (47.5%) were observed in the recovery room or
dmitted to the intensive care unit, with no significant
ifferences of mean stay in the IFU (11.2 14.5 hours) vs
he OL group (13.9  12 hours; P  .23). Mean hospital
tay was similar between the IFU (4.3  1.3 days) and OL
roups (4.3  1.3 days; P  .83).
Table IV reports overall 30-day results. Mortality, ma-
or morbidity, technical success, clinical success, complica-
able III. Intraoperative adjunctive procedures
rocedure
IFU
(n  121)
OL
(n  56)
No. (%) No. (%)
liac stenting for branch stenosis 19 8
enal stenting 1 0
roximal aortic cuff 0 1
ypogastric embolization 5 3
em-fem prosthetic crossover bypass 3 1
emoral endarterectomy 1 0
neurysmectomy femoral artery 1 0
otal 30 (24.8) 13 (23.2)
FU, Instructions for use; OL, off label.
able IV. Overall 30-day results
esult
IFU
(n  121)
OL
(n  56)
PNo. (%) No. (%)
echnical success 121 (100) 54 (96.4) .1
linical success 117 (96.7) 54 (96.4) .62
ortality 2 (1.6) 1 (1.8) .68
ajor morbidity 11 (9.1) 6 (10.7) .46
ystemic complications 9 (7.4) 8 (14.3) .12
evice-related complications 2 (1.6) 2 (3.6) .38
ccess site complications 5 (4.1) 0 .14
ostimplantation syndrome 16 (13.2) 9 (16.1) .38
einterventions 4 (3.3) 0 .21
FU, Instructions for use; OL, off label.ions, and reinterventions rates were similar between the
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Volume 54, Number 2 Torsello et al 303two groups. Incidence of postimplantation syndrome, de-
fined as the presence in the postoperative period of fever,
leukocytosis, or coagulation disturbances,21 was similar
between the two groups. Four reinterventions were per-
formed in the IFU group (2 sutures of arteriotomy for false
aneurysm in access site, 1 thrombectomy and 1 femoro-
femoral crossover prosthetic bypass graft for limb graft
thrombosis). The 30-day CT examinations showed a type I
endoleak in two OL patients (3.6%), but no type I endoleak
was detected in the IFU patients (P  .09). One type I
endoleak was successfully treated with an aortic cuff exten-
sion at 3 months, while the remaining endoleak occurred in
a patient with acute coronary syndrome, who is still under
surveillance and will be treated after stabilization of his
cardiac status.
Univariate analysis demonstrated that none of the pre-
operative or intraoperative factors significantly affected 30-
day mortality, major morbidity, or technical or clinical
success rates in the OL group. Multivariate analysis con-
firmed that none of the examined factors affected early
outcomes.
Intermediate (1-year) results. Follow-up was avail-
Fig 1. Estimated 1-year freedom from any device-rel
patients at risk and standard error values for each group)able in 169 patients (95.5%), with an overall median dura- 5ion of 6 months (range, 1-24 months). During follow-up,
hree patients died (2 IFU and 1 OL), with one aneurysm-
elated death in the OL group (AAA rupture secondary to
late type I endoleak diagnosed 3 months after the proce-
ure). No conversion to open repair or graft migration
ccurred. Four further reinterventions were performed
uring the follow-up, consisting of two femorofemoral
rossover prosthetic bypass grafts for limb graft thrombosis
nd one proximal aortic cuff extension for a type I endoleak
n the OL group and one embolization of the inferior
esenteric artery for type II endoleak in the IFU group.
There were no differences between the two groups in
stimated survival at 1 year (95.6% in IFU and 95.3% in OL,
espectively; P  .89). Furthermore, estimated freedom
rom any device-related reinterventions at 1 year (95.2% in
FU and 91.7% in OL; P  .67; Fig 1) and estimated
reedom from graft thrombosis (98.3% in IFU and 94.4% in
L; P .41) were similar between the two groups. Finally,
stimated 1-year freedom from type I endoleak was 100% in
he IFU group vs 93.3% in the OL patients (P .01; Fig 2).
During the follow-up, a statistically significant overall
eduction in both groups of the mean sac diameter from
reinterventions (Kaplan-Meier curve with number of
, Instructions for use; OL, off-label.ated4.1 to 47.6 mm was detected (P  .001).
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August 2011304 Torsello et alUnivariate analysis demonstrated that none of the pre-
operative or intraoperative factors significantly affected the
1-year rates of survival, freedom from any device related
interventions, freedom from graft thrombosis, and freedom
from type I endoleak in the OL group. Multivariate analysis
confirmed that none of the examined factors could be
considered an independent predictor of poor outcomes at 1
year in the OL group.
DISCUSSION
Successful outcomes with EVAR require accurate pre-
operative planning focused on morphologic assessments of
the landing zones (proximal aortic neck and iliac arter-
ies).22 In particular, unfavorable anatomy of the proximal
aortic neck is responsible for about 60% of the patients who
are excluded from EVAR.6
Patients at high surgical risk, in whom open repair is
not an option, intuitively would have the greatest benefits
from EVAR.5,20 Unfortunately, patients with severe co-
morbidities often have anatomically complex lesions that
are not amenable to EVAR, which suggests an association
Fig 2. Estimated 1-year freedom from type I endolea
standard error values for each group). IFU, Instructionsbetween the clinical status and the anatomic complexity of ihe infrarenal aorta.6 Lederle et al20 demonstrated that the
-year incidence of probable AAA rupture in patients unfit
or open repair was 9.4% for AAA of 5.5 to 5.9 cm, 10.2%
or AAA of 6.0 to 6.9 cm (19.1% for the subgroup of
.5-6.9 cm), and 32.5% for AAA of7.0 cm; these patients
ould benefit from EVAR, also stressing the indications for
his less invasive modality of treatment.
For this reason, many physicians must treat patients
sing devices in an OL manner to offer a less invasive
reatment option to patients who are otherwise not feasible
or open repair but yet need treatment. Abbruzzese et al16
valuated first-generation devices, including the Cook Ze-
ith, the Gore Excluder, and the Medtronic AneuRx, and
emonstrated that overall actuarial 5-year freedom from
neurysm-related death, reintervention, and graft-related
dverse events were similar among the devices. Further-
ore, graft placement outside of IFU was associated with
imilar 5-year freedom from aneurysm-related deaths, mi-
rations, and reinterventions, but there was a significantly
ower freedom from graft-related adverse events (74% out-
ide IFU vs 86% within IFU), likely related to a higher
plan-Meier curve with number of patients at risk and
se; OL, off-label.k (Kancidence of graft thrombosis (2.3% outside IFU vs 0.3%
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Volume 54, Number 2 Torsello et al 305within IFU; P  .026). They concluded that application
outside of anatomically specific IFU variables had an incre-
mental negative effect on late results, indicating that adher-
ence to such IFU guidelines is appropriate to clinical prac-
tice. However, the outcomes with newer generation
devices with different device profiles and attachment mech-
anisms when placed outside the IFU are unknown for
EVAR.13-19
In our present series, we used the Endurant stent graft
in patients with normal and hostile aortoiliac anatomy. This
new-generation device obtained the Conformité Euro-
péene mark in July 2008 and is commercially available in all
European countries. The main features of this endograft
have been described in other reports.17-19 The device has
greater flexibility due to shorter and wire-formed M-shaped
body stents, and this increased flexibility allows the stent
graft to be successfully used in aneurysms with severely
angulated and tortuous anatomies. The suprarenal anchor-
ing pins and the controlled release of the top stent ensure
the exact proximal fixation to the aortic wall and reduce the
risk of migration.
In our early experience,17 the Endurant stent graft was
used to treat AAAs with a severely angulated (60°) and
short neck (10 mm) in patients for whom open repair
could be hazardous. In the current series, patients treated
under OL conditions were older; this factor plays into the
physicians and patients wishing to be treated with a less
invasive option to manage the aneurysm and to prevent
aneurysm-related death. A recent report by Prenner et al23
supports this approach for this group of patients.
Patients treated under OL conditions had a mean
greater diameter of the aneurysmal sac compared with the
patients of the IFU group. Aneurysm size could be consid-
ered as a surrogate marker of complex anatomy or of severe
comorbidities, or both; a large population-based audit con-
ducted in Australia identified an increased risk of death in
patients with a sac diameter 65 mm.24 Patients with a
complex anatomy of the proximal aortic neck (OL group)
even presented a more complex anatomy of the iliac axis,
with a higher mean angulation of the iliac vessels. So, the
complex anatomy of the infrarenal aorta involved not only
the proximal aortic neck but also the aneurysm size and the
iliac axis.
Concerning intraoperative details, the procedures per-
formed in the OL patients lasted longer than those in
patients of the IFU group. The increased duration of the
procedure resulted in more radiation with a higher expo-
sure to radiation for both patients and surgeons.25,26
In this series, EVAR showed similar results in IFU and
OL patients in mortality, major morbidity, technical suc-
cess, and clinical success. These results are in contrast with
previously reported data10,27 that demonstrated a higher
number of perioperative complications, reinterventions,
and deaths in patients with a very short proximal aortic neck
(10 mm). Similar results were also reported in the Euro-
pean Collaborators on Stent-Graft Techniques for Aortic
Aneurysm Repair (EUROSTAR) registry. A neck length
15 mm and an angulation 60° were independent riskactors of early type I endoleak and graft migration.9,28 Also
n our experience, the 30-day rate of type I endoleak was
igher in the OL group (3.6% vs 0%). Nevertheless, after a
ollow-up of 1 year, this finding did not have an effect on
he results for survival or freedom from any device-related
einterventions. AbuRahma et al10 demonstrated late rein-
erventions were not more frequent in patients with a very
hort proximal aortic neck, despite a higher rate of early and
ate type I endoleak; our outcomes support these data.
This study has some limitations, including that it ap-
lies to a single device and does not represent the hetero-
eneity of devices used for EVAR, as reported in similar
eries.10,16 Furthermore, the current follow-up is relatively
hort with a median follow-up of only 6 months, and we
btained comparable results only in the intermediate pe-
iod (1 year) with 42 IFU and 20 OL patients with a
omplete 1-year follow-up. Continued surveillance of these
atients will be necessary to evaluate the fixation of the
tent-graft over a longer period of time due to the contin-
ed risk of neck expansion, development of type I en-
oleaks, and migration.
Furthermore, to achieve these results, extensive experi-
nce in EVAR as well as with the Endurant stent graft
ithin indications should be obtained before extending the
ndications.
ONCLUSIONS
In patients with both normal and complex anatomy of
he proximal aortic neck, the Endurant stent graft obtained
cceptable results. However, the expansion of the indica-
ions for EVAR even in patients considered OL was respon-
ible of a higher risk of type I endoleak, although the early
nd intermediate results in survival, major complications,
nd reinterventions rates were similar to those obtained in
atients operated on according to the indications of the
anufacturer. This could justify a cautious application of
VAR also in patients outside of the device-specific IFU.
inally, further studies are needed to evaluate the long-
erm results of this new-generation device in normal and
omplex morphologic situations.
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